Insider filing · BSX
Jeffrey B. Mirviss
EVP&Pres, Periph Intervent
profile →
Boston Scientific Corporation
BSX · Healthcare · 79 filings in 24 months
ticker →
Jeffrey B. Mirviss sold $1.4M of Boston Scientific (BSX)
Executed Feb 12 2025, disclosed Feb 13 2025, 1 day later.
Value, as filed
$1.4M
13,022 sh × $105.06
Executed
Feb 12 2025
the trade date, as filed
Disclosed
Feb 13 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JMJeffrey B. Mirviss (EVP&Pres, Periph Intervent) filed 4 Form 4 reports in the past 24 months (0 purchases, 4 sales), most often in Boston Scientific Corporation (BSX). The largest single filing was $1.4M of BSX (13,022 sh × $105.06, as filed), executed Feb 12 2025.
The name
BSXHealthcare · Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties wor…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jeffrey B. Mirviss in BSX
BSXSALE
Boston Scientific Corporation
$767K7,363 sh across 2 lots
Exec Feb 24 2025
Filed Feb 25 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation $159K
1,510 sh × $105.35
Exec Feb 19 2025
Filed Feb 19 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation $643K
7,152 sh × $89.86
Exec Jan 3 2025
Filed Jan 3 2025 · 5:30 PM ET